TABLE OF CONTENTS

Volume 43, Issue 2 (January 2018)

Top

Commentary

Combinatorial Psycho-Pharmacological Approaches for the Treatment of Abnormal Aggression

Sam A Golden and Aki Takahashi

Neuropsychopharmacology 43: 233-234; advance online publication, October 11, 2017; doi:10.1038/npp.2017.174

Top

Original Articles

Social Learning Requires Plasticity Enhanced by Fluoxetine Through Prefrontal Bdnf-TrkB Signaling to Limit Aggression Induced by Post-Weaning Social Isolation

Éva Mikics, Ramon Guirado, Juzoh Umemori, Máté Tóth, László Biró, Christina Miskolczi, Diána Balázsfi, Dóra Zelena, Eero Castrén, József Haller and Nina N Karpova

Neuropsychopharmacology 43: 235-245; advance online publication, August 9, 2017; doi:10.1038/npp.2017.142

Opioid Release after High-Intensity Interval Training in Healthy Human Subjects

Tiina Saanijoki, Lauri Tuominen, Jetro J Tuulari, Lauri Nummenmaa, Eveliina Arponen, Kari Kalliokoski and Jussi Hirvonen

Neuropsychopharmacology 43: 246-254; advance online publication, August 16, 2017; doi:10.1038/npp.2017.148

In Vivo Fiber Photometry Reveals Signature of Future Stress Susceptibility in Nucleus Accumbens

Jessie Muir, Zachary S Lorsch, Charu Ramakrishnan, Karl Deisseroth, Eric J Nestler, Erin S Calipari and Rosemary C Bagot

Neuropsychopharmacology 43: 255-263; advance online publication, July 5, 2017; doi:10.1038/npp.2017.122

A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort

Gary Brucato, Paul S Appelbaum, Jeffrey A Lieberman, Melanie M Wall, Tianshu Feng, Michael D Masucci, Rebecca Altschuler and Ragy R Girgis

Neuropsychopharmacology 43: 264-271; advance online publication, August 9, 2017; doi:10.1038/npp.2017.151

Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress

Peter J Hamilton, Dominika J Burek, Sonia I Lombroso, Rachael L Neve, Alfred J Robison, Eric J Nestler and Elizabeth A Heller

Neuropsychopharmacology 43: 272-284; advance online publication, June 7, 2017; doi:10.1038/npp.2017.88

A Key Role for Neurotensin in Chronic-Stress-Induced Anxiety-Like Behavior in Rats

Catherine P Normandeau, Ana Paula Ventura-Silva, Emily R Hawken, Staci Angelis, Calvin Sjaarda, Xudong Liu, José Miguel Pêgo and É C Dumont

Neuropsychopharmacology 43: 285-293; advance online publication, August 16, 2017; doi:10.1038/npp.2017.134

Oxytocin Modulates Attention Switching Between Interoceptive Signals and External Social Cues

Shuxia Yao, Benjamin Becker, Weihua Zhao, Zhiying Zhao, Juan Kou, Xiaole Ma, Yayuan Geng, Peng Ren and Keith M Kendrick

Neuropsychopharmacology 43: 294-301; advance online publication, September 27, 2017; doi:10.1038/npp.2017.189

Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression

Yu-Cheng Ho, Tzer-Bin Lin, Ming-Chun Hsieh, Cheng-Yuan Lai, Dylan Chou, Yat-Pang Chau, Gin-Den Chen and Hsien-Yu Peng

Neuropsychopharmacology 43: 302-312; advance online publication, October 11, 2017; doi:10.1038/npp.2017.199

Dopamine and Stress System Modulation of Sex Differences in Decision Making

Polymnia Georgiou, Panos Zanos, Shambhu Bhat, J Kathleen Tracy, Istvan J Merchenthaler, Margaret M McCarthy and Todd D Gould

Neuropsychopharmacology 43: 313-324; advance online publication, August 23, 2017; doi:10.1038/npp.2017.161

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Jerome H Taylor, Angeli Landeros-Weisenberger, Catherine Coughlin, Jilian Mulqueen, Jessica A Johnson, Daniel Gabriel, Margot O Reed, Ewgeni Jakubovski and Michael H Bloch

Neuropsychopharmacology 43: 325-333; advance online publication, October 11, 2017; doi:10.1038/npp.2017.194

Combined Effects of Glucocorticoid and Noradrenergic Activity on Loss Aversion

Zsofia Margittai, Gideon Nave, Marijn Van Wingerden, Alfons Schnitzler, Lars Schwabe and Tobias Kalenscher

Neuropsychopharmacology 43: 334-341; advance online publication, May 10, 2017; doi:10.1038/npp.2017.75

Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model Open

Rebecca T Emeny, Jens Baumert, Anthony S Zannas, Sonja Kunze, Simone Wahl, Stella Iurato, Janine Arloth, Angelika Erhardt, Georgia Balsevich, Mathias V Schmidt, Peter Weber, Anja Kretschmer, Liliane Pfeiffer, Johannes Kruse, Konstantin Strauch, Michael Roden, Christian Herder, Wolfgang Koenig, Christian Gieger, Melanie Waldenberger, Annette Peters, Elisabeth B Binder and Karl-Heinz Ladwig

Neuropsychopharmacology 43: 342-353; advance online publication, June 21, 2017; doi:10.1038/npp.2017.102

Pharmacological Manipulation of Cortical Inhibition in the Dorsolateral Prefrontal Cortex

Bahar Salavati, Tarek K Rajji, Reza Zomorrodi, Daniel M Blumberger, Robert Chen, Bruce G Pollock and Zafiris J Daskalakis

Neuropsychopharmacology 43: 354-361; advance online publication, June 21, 2017; doi:10.1038/npp.2017.104

κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition

Antony D Abraham, Harrison M Fontaine, Allisa J Song, Mackenzie M Andrews, Madison A Baird, Brigitte L Kieffer, Benjamin B Land and Charles Chavkin

Neuropsychopharmacology 43: 362-372; advance online publication, August 23, 2017; doi:10.1038/npp.2017.133

Memory Retention Involves the Ventrolateral Orbitofrontal Cortex: Comparison with the Basolateral Amygdala

Kelsey S Zimmermann, Chen-chen Li, Donald G Rainnie, Kerry J Ressler and Shanmon L Gourley

Neuropsychopharmacology 43: 373-383; advance online publication, August 23, 2017; doi:10.1038/npp.2017.139

Neural Underpinnings of Cortisol Effects on Fear Extinction

Christian Josef Merz, Tanja Christina Hamacher-Dang, Rudolf Stark, Oliver Tobias Wolf and Andrea Hermann

Neuropsychopharmacology 43: 384-392; advance online publication, October 25, 2017; doi:10.1038/npp.2017.227

Failure to Inactivate Nuclear GSK3β by Ser389-Phosphorylation Leads to Focal Neuronal Death and Prolonged Fear Response

Tina M Thornton, Brendan Hare, Sandra Colié, William W Pendlebury, Angel R Nebreda, William Falls, Diane M Jaworski and Mercedes Rincon

Neuropsychopharmacology 43: 393-405; advance online publication, September 20, 2017; doi:10.1038/npp.2017.187

The 5-HTTLPR Polymorphism Affects Network-Based Functional Connectivity in the Visual-Limbic System in Healthy Adults

Hengyi Cao, Anais Harneit, Henrik Walter, Susanne Erk, Urs Braun, Carolin Moessnang, Lena S Geiger, Zhenxiang Zang, Sebastian Mohnke, Andreas Heinz, Nina Romanczuk-Seiferth, Thomas Mühleisen, Manuel Mattheisen, Stephanie H Witt, Sven Cichon, Markus M Nöthen, Marcella Rietschel, Andreas Meyer-Lindenberg and Heike Tost

Neuropsychopharmacology 43: 406-414; advance online publication, July 5, 2017; doi:10.1038/npp.2017.121

Activation of the GABAergic Parafacial Zone Maintains Sleep and Counteracts the Wake-Promoting Action of the Psychostimulants Armodafinil and Caffeine

Christelle Anaclet, Kobi Griffith and Patrick M Fuller

Neuropsychopharmacology 43: 415-425; advance online publication, August 16, 2017; doi:10.1038/npp.2017.152

The Insular Cortex Dynamically Maps Changes in Cardiorespiratory Interoception Open

Mahlega S Hassanpour, W Kyle Simmons, Justin S Feinstein, Qingfei Luo, Rachel C Lapidus, Jerzy Bodurka, Martin P Paulus and Sahib S Khalsa

Neuropsychopharmacology 43: 426-434; advance online publication, August 9, 2017; doi:10.1038/npp.2017.154

Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator

Puja K Parekh, Michelle M Sidor, Andrea Gillman, Darius Becker-Krail, Letizia Bettelini, Roberto Arban, Giuseppe S Alvaro, Erika Zambello, Chiara Mutinelli, Yanhua Huang, Charles H Large and Colleen A McClung

Neuropsychopharmacology 43: 435-444; advance online publication, September 27, 2017; doi:10.1038/npp.2017.155

Telomere Length and Bipolar Disorder Open

Timothy R Powell, Danai Dima, Sophia Frangou and Gerome Breen

Neuropsychopharmacology 43: 445-453; advance online publication, July 26, 2017; doi:10.1038/npp.2017.125

Top

Corrigendum

Telomere Length and Bipolar Disorder Open

Timothy R Powell, Danai Dima, Sophia Frangou and Gerome Breen

Neuropsychopharmacology 43: 454; doi:10.1038/npp.2017.239

Top

In Memoriam

Carmen Keith Conners FREE

Bernard J Carroll

Neuropsychopharmacology 43: 455; doi:10.1038/npp.2017.240

Top

Retraction

Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 a and AP-2 b in Frontal Cortex of Rats Treated with Lithium for 6 Weeks FREE

Jagadeesh S Rao, Stanley I Rapoport and Francesca Bosetti

Neuropsychopharmacology 43: 456; doi:10.1038/npp.2017.237

Extra navigation

.
ADVERTISEMENT